Patents
US 11324720 B2: Antiproliferative DNA polymerase inhibitor
- Granted
- 2022-05-10
- Filed
- 2019-10-21 application 16659283
- Type
- Utility · 12 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Methods for inhibiting cell growth, inhibiting DNA polymerase activity, and inhibiting DNA replication and repair are provided. In a method of inhibiting cell growth, a cell, such as a cancer cell, is contacted with zelpolib or a derivative or pharmaceutically acceptable salt thereof. The cell growth can be inhibited in vivo, and in certain embodiments, the cell growth is inhibited in vitro. In a method for inhibiting DNA polymerase activity, a DNA polymerase is contacted with zelpolib or a derivative or pharmaceutically acceptable salt thereof. In certain embodiments, the DNA polymerase is Pol δ. In a method for inhibiting DNA replication and repair, a cell, such as a cancer cell, is contacted with zelpolib or a derivative or pharmaceutically acceptable salt thereof. The DNA replication and repair can be inhibited in vivo, and in certain embodiments, the DNA replication and repair is inhibited in vitro.
Source: PVGPATDIS, file of 2026-04-10 (ipg220510.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| NEW YORK MEDICAL COLLEGE 19 patents | US company or organization | Valhalla, NY | New York Medical College College or university EXACT high confidence: identical full name and state NEW YORK MEDICAL COLLEGE Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Zhongtao Zhang | Valhalla, NY | 4 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/381 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2023-04-19 | Assignment Assignment of assignor's interest | MISHRA, BHANVI, DR. signed 2023-04-18 ZHANG, SUFANG, DR. signed 2023-04-14 LEE, MARIETTA, DR. signed 2023-04-15 | NEW YORK MEDICAL COLLEGE VALHALLA, NY | 63373/603 | PASDL, file of 2026-10-15 |
| 2019-11-22 | Assignment Assignment of assignor's interest | ZHANG, ZHONGTAO signed 2019-11-19 | NEW YORK MEDICAL COLLEGE VALHALLA, NY | 51092/19 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.